10-K: Select Medical Holdings Reports $5.2 Billion Revenue for 2024, Completes Concentra Spin-Off

Sentiment:

Annual Results


Select Medical Holdings Corporation announces its 2024 financial results, including a revenue of $5.2 billion and the completion of the spin-off of Concentra.

Summary

  • Select Medical Holdings Corporation reported a revenue of $5,187.1 million for the year ended December 31, 2024.
  • The company completed the spin-off of Concentra on November 25, 2024, distributing all remaining equity interest to its stockholders.
  • Following the Concentra distribution, Select Medical now manages its company through three business segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation.
  • The critical illness recovery hospital segment contributed approximately 47% of the total revenue, the rehabilitation hospital segment contributed approximately 21%, and the outpatient rehabilitation segment contributed approximately 24%.
  • As of December 31, 2024, Select Medical operated 104 critical illness recovery hospitals, 35 rehabilitation hospitals, and 1,914 outpatient rehabilitation clinics.
  • Net proceeds from Concentra's IPO were $499.7 million, after deducting underwriting discounts and commissions of $29.1 million.
  • Holders of the Company's common stock received 0.806971 shares of Concentra common stock for each outstanding share of the Company's common stock they owned as of November 18, 2024.
  • The standard federal rate for fiscal year 2025 is $49,383, an increase from the standard federal rate applicable during fiscal year 2024 of $48,117.
  • The fixed-loss amount for high cost outlier cases paid under LTCH-PPS is $77,048, an increase from the fixed-loss amount in the 2024 fiscal year of $59,873.
  • The standard payment conversion factor for discharges for fiscal year 2025 was set at $18,907, an increase from the standard payment conversion factor applicable during fiscal year 2024 of $18,541.

Sentiment

Score: 7

Explanation: The document presents a balanced view with positive revenue growth and strategic initiatives, but also acknowledges risks and challenges, resulting in a moderately positive sentiment.

Positives

  • Revenue increased by 7.5% compared to the previous year.
  • The company has a strong focus on providing high-quality medical care within its facilities.
  • The company is well-positioned to capitalize on acquisition opportunities.
  • The company has an experienced and proven management team.
  • The company has a strong cash flow.

Negatives

  • The company is subject to extensive federal, state, and local laws and regulations.
  • The company faces competition from other hospitals, clinics, and healthcare providers.
  • The company is exposed to fluctuating market conditions, including rising interest rates.
  • The company is subject to potential legal and reputational harm from security breaches of its information technology systems.
  • The company is subject to potential recoupments of Medicare outlier payments from its LTCHs.

Risks

  • Changes in government reimbursement for services could reduce revenue and profitability.
  • Adverse economic conditions, including inflation, could increase labor and other costs.
  • Shortages in qualified nurses, therapists, and physicians could limit the ability to staff facilities.
  • Failure to maintain Medicare certifications may cause revenue and profitability to decline.
  • Acquisitions or joint ventures may prove difficult or unsuccessful.
  • Competition may limit the ability to grow and result in a decrease in revenue and profitability.
  • The loss of key members of the management team could significantly disrupt operations.
  • A security breach of information technology systems may subject the company to potential legal and reputational harm.
  • CMS finalized record increases to the high cost outlier fixed loss amount for LTCH-PPS standard Federal payment rate cases in FY 2024 and FY 2025 and, unless there are significant reforms, the fixed loss amount will likely increase again in FY 2026, which will result in fewer cases qualifying for high cost outlier payments and often lower payments for the cases that do qualify.

Future Outlook

The company may grow through opportunistic acquisitions and intends to open new outpatient rehabilitation clinics in local areas that it currently serves.

Industry Context

The document provides insight into the operations and financial performance of a major player in the critical illness recovery, rehabilitation, and outpatient rehabilitation sectors, reflecting the increasing demand for post-acute care services driven by an aging population and complex medical needs.

Comparison to Industry Standards

  • Encompass Health Corporation is a major competitor in the rehabilitation hospital segment.
  • ScionHealth is a competitor in the critical illness recovery hospital segment.
  • Athletico Physical Therapy, ATI Physical Therapy, U.S. Physical Therapy, and Upstream Rehabilitation are competitors in the outpatient rehabilitation segment.

Legal Proceedings

  • The company is involved in an investigation by the U.S. Attorneys Office for the Western District of Oklahoma regarding billing practices at Select Specialty Hospital Oklahoma City, Inc.
  • The company is also subject to an investigation by the DOJ and HHS regarding billing for physical therapy services at its outpatient therapy clinics.

Related Party Transactions

  • The company leases its corporate headquarters from companies owned by a related party.
  • The company provides contracted services and charges management fees to related parties affiliated through its equity method investments.

Stakeholder Impact

  • Shareholders received a tax-free distribution of Concentra shares.
  • Employees are subject to insider trading policies and restrictions.
  • Patients benefit from the company's focus on high-quality care and specialized treatment programs.
  • Payors are affected by changes in reimbursement rates and cost containment initiatives.

Next Steps

  • The company may pursue selective acquisitions within each of its business segments.
  • The company intends to open new outpatient rehabilitation clinics in local areas it currently serves.

Key Dates

DateDescription
1997Select Medical began operations.
March 6, 2017Select Medical entered into a senior secured credit agreement.
January 31, 2020HHS declared a public health emergency due to COVID-19.
March 13, 2020President Trump declared a national emergency due to COVID-19.
July 26, 2024Concentra completed its IPO.
November 25, 2024Select Medical completed the distribution of Concentra shares to its stockholders.
December 3, 2024Select Medical issued $550 million of 6.250% senior notes due 2032 and amended its credit agreement.
December 31, 2025The common stock repurchase program will remain in effect until this date.

Keywords

Select Medical Holdings, financial results, revenue, critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation, Medicare, LTCH, IRF, Concentra, spin-off, acquisitions, regulations, risk factors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.